Histopathology Outsourcing for Portsmouth Hospitals University Trust Cellular Pathology department
A Contract Award Notice
by SOUTH OF ENGLAND PROCUREMENT CENTRE
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £950K
- Sector
- HEALTH
- Published
- 16 Aug 2024
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
South East England:
1 buyer
1 supplier
- Poundbury Cancer Institute Dorchester
Description
Outsourcing of Histopathology cases, including provision of both laboratory technical and Consultant diagnostic reporting services, attendance at MDT.
Total Quantity or Scope
Outsourcing of Histopathology cases, including provision of both laboratory technical and Consultant diagnostic reporting services, attendance at MDT, courier services
Award Detail
1 | Poundbury Cancer Institute (Dorchester)
|
Renewal Options
Procurement Selection Regime Direct Award Process C could be used to extend the agrement/contract
Award Criteria
price | _ |
CPV Codes
- 85111800 - Pathology services
Indicators
- Options are available.
Legal Justification
'This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by [Add date]. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR'.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** 'This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by [Add date]. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.' The email address where written representations should be sent is jonathan.peer@portshosp.nhs.uk The award decision-makers are the Cellular Pathology Laboratory Manager and the Clinical Support Care Group Manager There are no declared conflicts or potential conflicts of interest of individuals making the decision related to this award. In reviewing the Key Criteria, the following were considered to be the most important:- Value and service sustainability. In addition to this, continuing with Poundbury gives the Trust continuity of service having built up an existing relationship between PHU Pathologists, clinicians and surgical teams. Poundbury Pathologists attend PHU MDT's when required and are therefore experienced with the Trust's surgical and clinical processes. Poundbury Pathologists participate in the national dermal EQA scheme which is an ISO15189 accreditation standard requirement The provider was originally chosen by NHSE to provide post pandemic recovery Histopathology outsourcing support for breast screening and have further supported PHU with breast, skin, gynae, urology and GI reporting. The provider meets the basic selection criteria, in particular 'technical and professional ability' in that they offer specific technical expertise in Histopathology breast reporting and have established a relationship with PHU clinical teams so can discuss cases confidently at MDT, due to knowledge of PHU surgical and clinical processes. The PHU Cellular Pathology department now also have a deficit of reporting capacity for other tumour groups such as skin, gynae, upper and lower GI and Urology and have used this provider to support with further outsourcing, maintaining existing clinical relationships. The provider can offer Consultants registered with the relevant EQA schemes which is an important factor for patient safety and accreditation. The provider is considered to give good value, with a bespoke PHU pricing structure negotiated based upon workload points. The contract does not state minimum activity levels therefore PHU are not committed to sending a certain amount of work and can use the service as and when required.
Reference
- ocds-h6vhtk-048bb9
- FTS 026184-2024